We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy 3 Janus Henderson Mutual Funds for a Growth Portfolio
Read MoreHide Full Article
Founded in 1934, Janus Henderson is a global investment management company that provides diverse mutual funds in equities, fixed-income and multi-asset strategies. Janus Henderson was created by the 2017 merger between Janus Capital Group and Henderson Global Investors and has $378.7 billion in assets under management, with more than 340 investment professionals working worldwide. Janus Henderson follows deep research, proprietary analysis and collaboration to find opportunities and manage risk in its investment approach. All these factors make it a reliable investment option.
We have chosen three Janus Henderson mutual funds — Janus Henderson Research (JNRFX - Free Report) , Janus Henderson Global Life Sciences (JNGLX - Free Report) and Janus Henderson Enterprise Fund (JDMAX - Free Report) — that investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Janus Henderson Research fund seeks to generate additional income by lending up to one-third of its total assets to qualified broker-dealers and institutions, either on a short-term or long-term basis, as determined at loan origination. JNRFX invests in common stocks for growth potential, ranging from large companies to small and emerging firms.
Joshua Cummings has been the lead manager of JNRFX since Jan. 26, 2024. Most of the fund's holdings were in companies such as NVIDIA Corp (12.3%), Microsoft Corp (11.4%) and Apple Inc. (6.9%) as of Sept. 30, 2024.
JNRFX's 3-year and 5-year returns are 15.2% and 17.5%, respectively. Its annual expense ratio is 0.67%. JNRFX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds, please click here.
Janus Henderson Global Life Sciences fund primarily invests in equity securities issued by companies engaged in life sciences orientation.
Andy Acker has been the lead manager of JNGLX since May 1, 2007. Most of the fund's holdings were in companies like Eli Lilly and Co (9%), UnitedHealth Group Inc. (6.6%) and Novo Nordisk A/S (3.7%) as of Dec. 31, 2024.
JNGLX's 3-year and 5-year returns are 7.8% and 10.8%, respectively. Its annual expense ratio is 0.80%. JNGLX has a Zacks Mutual Fund Rank #1.
Janus Henderson Enterprise Fund invests most of its assets in equity assets of mid-sized companies. JDMAX advisors also invest in foreign securities.
Brian Demain has been the lead manager of JDMAX since Nov. 1, 2007. Most of the fund's holdings were in companies like Constellation Software Inc. (4.4%), GoDaddy Inc. (4.3%) and SS&C Technologies Holdings, Inc. (3.3%) as of Dec. 31, 2024.
JDMAX's 3-year and 5-year returns are 7.3% and 11.6%, respectively. Its annual expense ratio is 1.11%. JDMAX has a Zacks Mutual Fund Rank #1.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Buy 3 Janus Henderson Mutual Funds for a Growth Portfolio
Founded in 1934, Janus Henderson is a global investment management company that provides diverse mutual funds in equities, fixed-income and multi-asset strategies. Janus Henderson was created by the 2017 merger between Janus Capital Group and Henderson Global Investors and has $378.7 billion in assets under management, with more than 340 investment professionals working worldwide. Janus Henderson follows deep research, proprietary analysis and collaboration to find opportunities and manage risk in its investment approach. All these factors make it a reliable investment option.
We have chosen three Janus Henderson mutual funds — Janus Henderson Research (JNRFX - Free Report) , Janus Henderson Global Life Sciences (JNGLX - Free Report) and Janus Henderson Enterprise Fund (JDMAX - Free Report) — that investors should buy now for the long term. These funds have a Zacks Mutual Fund Rank #1 (Strong Buy) or 2 (Buy), positive three-year and five-year annualized returns, minimum initial investments within $5000 and expense ratios considerably lower than the category average. So, these funds have provided a comparatively stronger performance and carry a lower fee.
Janus Henderson Research fund seeks to generate additional income by lending up to one-third of its total assets to qualified broker-dealers and institutions, either on a short-term or long-term basis, as determined at loan origination. JNRFX invests in common stocks for growth potential, ranging from large companies to small and emerging firms.
Joshua Cummings has been the lead manager of JNRFX since Jan. 26, 2024. Most of the fund's holdings were in companies such as NVIDIA Corp (12.3%), Microsoft Corp (11.4%) and Apple Inc. (6.9%) as of Sept. 30, 2024.
JNRFX's 3-year and 5-year returns are 15.2% and 17.5%, respectively. Its annual expense ratio is 0.67%. JNRFX has a Zacks Mutual Fund Rank #1.
To see how this fund performed compared to its category and other 1 and 2 Ranked Mutual Funds, please click here.
Janus Henderson Global Life Sciences fund primarily invests in equity securities issued by companies engaged in life sciences orientation.
Andy Acker has been the lead manager of JNGLX since May 1, 2007. Most of the fund's holdings were in companies like Eli Lilly and Co (9%), UnitedHealth Group Inc. (6.6%) and Novo Nordisk A/S (3.7%) as of Dec. 31, 2024.
JNGLX's 3-year and 5-year returns are 7.8% and 10.8%, respectively. Its annual expense ratio is 0.80%. JNGLX has a Zacks Mutual Fund Rank #1.
Janus Henderson Enterprise Fund invests most of its assets in equity assets of mid-sized companies. JDMAX advisors also invest in foreign securities.
Brian Demain has been the lead manager of JDMAX since Nov. 1, 2007. Most of the fund's holdings were in companies like Constellation Software Inc. (4.4%), GoDaddy Inc. (4.3%) and SS&C Technologies Holdings, Inc. (3.3%) as of Dec. 31, 2024.
JDMAX's 3-year and 5-year returns are 7.3% and 11.6%, respectively. Its annual expense ratio is 1.11%. JDMAX has a Zacks Mutual Fund Rank #1.
Want key mutual fund info delivered straight to your inbox?
Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>